Peapack Gladstone Financial Corp Charles River Laboratories International, Inc. Transaction History

Peapack Gladstone Financial Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$351.38 - $448.68 $230,153 - $293,885	-655 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$372.64 - $458.3 $47,697 - $58,662	-128 Reduced 16.35%	655 $270,000
Q2 2021 Aug 16, 2021	BUY	$294.17 - $371.65 $882 - $1,114	3 Added 0.38%	783 $290,000
Q1 2021 May 14, 2021	SELL	$249.67 - $299.48 $7,739 - $9,283	-31 Reduced 3.82%	780 $226,000
Q4 2020 Feb 16, 2021	SELL	$222.0 - $252.62 $27,528 - $31,324	-124 Reduced 13.26%	811 $203,000
Q3 2020 Nov 16, 2020	BUY	$175.56 - $226.45 $164,148 - $211,730	935 New	935 $212,000

696

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.96B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Peapack Gladstone Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Peapack Gladstone Financial Corp with notifications on news.